# P0 continuation 01 — 20 October 2026

Scope: independent preparatory engineering evidence for BV-002, BV-005 and BV-006. Task dependencies and approval requirements remain unchanged. The user's request to continue was not recorded as specialist or product signoff.

## Changes

- `tools/check-boundaries.mjs`: reject unregistered `@biovitai/`, `@/`, `~/` and `#` aliases, while allowing the existing contracts workspace. Check TypeScript import types, import-equals and static template imports. Reject direct infrastructure imports from application services and alternate network clients outside Gateway infrastructure. Correct the domain exception so an arbitrary package beginning with `zod` cannot pass as Zod.
- `tests/boundaries.test.mjs`: regression fixtures for those bypasses, with allowed shared-contract and Gateway dependencies retained.
- `docs/p0/approvals.json`: six explicit Pending approval records linked to their original task IDs and accountable roles. No reviewer, date, version or evidence is fabricated.
- `tools/check-p0-gate.mjs` and `tests/phase-gate.test.mjs`: require all seven P0 tasks Done plus populated approval records to open P0. Reject later-phase progress while P0 is closed and reject approval-dependent task completion without recorded approval. Test missing/duplicate records, incomplete evidence and successful synthetic approval records. Synthetic approvals exist only in test memory.
- `package.json`: regular lint/CI now checks the phase gate against tracker progress; `npm run gate:p0` explicitly requires the gate to be open and lists outstanding items otherwise.
- `eslint.config.mjs`: recognize the Node structuredClone global used by isolated test fixtures.
- `README.md`: document gate commands and expanded static-check scope.

The checker validates recorded fields, not approval authenticity, legal sufficiency or clinical expertise. Reviewers must verify the underlying evidence. Boundary rules remain a static baseline, not a network sandbox; new alias/transport conventions need checks before adoption.

## Validation

On Node **22.23.3**, `npx --yes --package=node@22 --call "node --version && npm run check"` passes formatting, lint, import boundaries, phase-gate guard, typecheck, build and **15 tests**. This closes the initial report's local Node 22 validation gap. Hosted Windows/Linux CI remains unexecuted.

`npm run gate:p0` correctly reports CLOSED and exits 1: six Pending approvals, BV-001 In Review, and BV-002–BV-007 Blocked. The guard in regular checks passes because no later-phase task has advanced. Both Python tracker/documentation validators pass, preserving all 60 requirements and 51 original task definitions. No tracker status, acceptance criteria or dependency was changed in this cycle; CSV/JSON/XLSX remain consistent.

The first validation run exposed a missing ESLint global declaration for structuredClone; it was corrected. An earlier Node 22 run overlapped active edits and reported formatting differences; the final run followed formatting and passed.

## Remaining gate

BV-001 Product/UX review remains the next eligible approval step. Accepted architecture, Security/Privacy data handling, a named independent clinical reviewer, reviewed Gateway contracts and Product/Legal launch-scope decisions remain required. No P1 feature, provider integration, database or production deployment has been started.
